All News

President Biden orders states to broaden vaccine eligibility by May 1; new data from Novavax, Pfizer point to high vaccine efficacy; Supreme Court will not hear arguments on Medicaid work requirements.

Reliable data on the costs of spinal muscular atrophy (SMA) illness are scarce, leaving key questions unanswered as new, high-priced therapies continue to emerge.

This week, the top news in managed care included CDC guidance on safe activities for fully vaccinated individuals; American Rescue Plan signed into law; new lung cancer screening criteria expand eligibility.

Medicare Advantage beneficiaries with type 2 diabetes (T2D) may be less likely than commercially insured individuals to be treated with newer medications to lower glucose levels, according to results of a retrospective cohort study published in JAMA Network Open.

The study, published on World Kidney Day, is the first to report the optimal amount of activity in patients with chronic kidney disease, according to the authors.

During a session presented at the America’s Health Insurance Plans (AHIP) National Health Policy Conference, Michael Chernew, PhD, the director of Healthcare Markets and Regulation Lab at Harvard Medical School, and Mark McClellan, MD, PhD, founding director at Duke Margolis Center for Health Policy, discussed the potential for Medicare innovation and reforms in 2021 and beyond.

In part 1 of the COPD Stakeholder Summit, a panel of experts about the burden of COPD, available treatments, and more.

Researchers discuss lifestyle interventions associated with improved outcomes in patients with obstructive sleep apnea, including weight management and alcohol and smoking cessation.

The $1.9 trillion spending package aimed at providing COVID-19 relief for those with low and middle incomes also represents the biggest investment in the exchange marketplaces created by the Affordable Care Act (ACA) since the landmark law was passed 11 years ago.

To adapt to a new requirement this year for all US hospitals to publicly post the costs for treatment services under every insurance plan, health systems should be prepared to field the range of questions that consumers may ask on issues such as outcomes data and cost for prospective services.

Today marks the 1-year anniversary of the World Health Organization declaring COVID-19 a pandemic; President Biden orders 100 million more Johnson & Johnson vaccines; 2020 saw a 15% increase in the US death rate.

During a session presented at the America’s Health Insurance Plans National Health Policy Conference, experts laid out potential policy priorities for states in the wake of the COVID-19 pandemic.

Updated lung cancer screening recommendations from the U.S. Preventive Services Task Force include 2 changes that will nearly double the number of people eligible for screening.

When comparing 1-step and 2-step approaches for diagnosing gestational diabetes among pregnant women, researchers found no significant between-group differences in the risks of primary outcomes relating to perinatal and maternal complications.

Study findings detail the researchers’ ability to prevent stroke in 11 patients ranging in age from 18 months to 15 years

Investigators sought to better understand increasing price trends, including those seen among disease-modifying drugs to treat multiple sclerosis (MS) and other neurological diseases.

Heart failure has been shown to be a contributing factor in more deaths in rural vs urban counties in which cardiovascular disease was pinpointed as the underlying cause of death.

Implementation of the free My Retina Tracker Genetic Testing Study program was associated with an increased proportion of patients with inherited retinal degeneration successfully obtaining genetic testing, according to analysis results published in JAMA Ophthalmology.

A study finds type 2 diabetes associated with an increased risk of developing Parkinson disease (PD), as well as faster progression of motor symptoms in those with PD.

More than a year into the COVID-19 pandemic, a new study suggests that individuals recovering from acute kidney injury stemming from COVID-19 will require kidney monitoring after they leave the hospital.

Research funded by the National Human Genome Research Institute has produced a 22-item guideline for the minimal polygenic risk score-related information that researchers should include in their studies.

Alaska removes COVID-19 vaccine eligibility restrictions; Affordable Care Act (ACA) health plan subsidies could increase under new relief bill; HHS is reviewing CDC COVID-19–related race and ethnicity data reporting.

The authors, from the National Health Council, the EveryLife Foundation for Rare Diseases, and the Innovation and Value Initiative, unveil a project to develop a blueprint for creating patient-centered core impact sets.

Idecabtagene vicleucel induced progression-free survival up to 20 months and a complete response in one-third of patients with multiple myeloma who had relapsed multiple times and had received at least 3 previous lines of treatment.

Sachin Jain, MD, MBA, FACP, explains why health systems shouldn't be afraid to analyze health care disparities within their own institutions.

In a session presented at America’s Health Insurance Plans (AHIP’s) National Health Policy Conference, federal health officials and health plan representatives highlighted successes of the country’s ongoing COVID-19 vaccine rollout, placing particular emphasis on the role equity plays in distribution.

On this episode of Managed Care Cast, Sarah Carroll, MPH, director of the Center for Care Transformation at AVIA, discusses the challenges of implementing digital health in underserved populations and the potential of these solutions to better address health disparities in the United States.

A review of evidence finds that oxygen therapy may be beneficial for all patients with pulmonary arterial hypertension, not just those who develop severe hypoxemia.